Search research articles
Contact Us
Filters
Showing results (171-180 of 218) with videos related to
Page
of 22
Sort By:
Journal of Pineal Research
|
August 1, 1997
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
P Lissoni, F Paolorossi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents
|
May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patients
P Lissoni, F Rovelli, M R Rivolta, et al.
Journal of Biological Regulators and Homeostatic Agents
|
March 7, 2000
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease
P Lissoni, L Vigore, R Ferranti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer
P Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers
|
April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumors
G Tancini, P Lissoni, S Barni, et al.
Tumori
|
September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]
G Bonadonna, G Beretta, G Tancini, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Relation between lymphocyte subpopulations and pineal function in patients with early or metastatic cancer
P Lissoni, S Barni, G Tancini, et al.
Tumori
|
April 30, 1987
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patients
S Barni, P Lissoni, G Tancini, et al.
Cancer
|
May 15, 1992
Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
E Tisi, P Lissoni, M Angeli, et al.
British Journal of Cancer
|
July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer
P Lissoni, E Tisi, S Barni, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 218) with videos related to
Sort By:
Page
of 22
Journal of Pineal Research
|
August 1, 1997
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
P Lissoni, F Paolorossi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents
|
May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patients
P Lissoni, F Rovelli, M R Rivolta, et al.
Journal of Biological Regulators and Homeostatic Agents
|
March 7, 2000
Circulating dendritic cells in early and advanced cancer patients: diminished percent in the metastatic disease
P Lissoni, L Vigore, R Ferranti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer
P Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers
|
April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumors
G Tancini, P Lissoni, S Barni, et al.
Tumori
|
September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]
G Bonadonna, G Beretta, G Tancini, et al.
Annals of the New York Academy of Sciences
|
January 1, 1988
Relation between lymphocyte subpopulations and pineal function in patients with early or metastatic cancer
P Lissoni, S Barni, G Tancini, et al.
Tumori
|
April 30, 1987
Acute effects of various chemotherapeutic combinations on hypophyseal and pineal hormone secretions in cancer patients
S Barni, P Lissoni, G Tancini, et al.
Cancer
|
May 15, 1992
Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
E Tisi, P Lissoni, M Angeli, et al.
British Journal of Cancer
|
July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer
P Lissoni, E Tisi, S Barni, et al.
Page
of 22